Skip to main content

Bariatric Surgery Linked to Lower All-Cancer Incidence Among Females

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 25, 2023 -- Among females, bariatric surgery is associated with lower all-cancer and obesity-related cancer incidence, according to a study published online Aug. 22 in Obesity.

Ted D. Adams, Ph.D., M.P.H., from Intermountain Healthcare in Salt Lake City, and colleagues conducted a retrospective study to examine the correlation of weight loss and cancer among post-bariatric surgery patients. A total of 21,837 bariatric surgery patients were matched by age, sex, and body mass index with a nonsurgical comparison group in a 1:1 ratio.

The researchers found that relative to the nonsurgery comparison group, bariatric surgery patients had a significantly lower risk for developing any cancers (hazard ratio [HR], 0.75). Cancer incidence was lower among female, but not male, bariatric surgery patients (HR, 0.67). Compared with nonsurgical female patients, female surgery patients had a reduced risk for obesity-related cancers (i.e., breast, ovarian, uterine, and colon; HR, 0.59). In female patients, cancer mortality was significantly lower after surgery (HR, 0.53).

"This research represents another important study that strongly supports the long-term benefits of weight loss surgery in the prevention of cancer," Adams said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Nudging Both Clinicians, Patients May Increase Serious Illness Conversations

TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

Racial Differences Seen in Financial Hardship Among Older Cancer Survivors

MONDAY, July 1, 2024 -- Income and area-level disadvantage are the largest contributors to racial differences in financial hardship among older U.S. adults with cancer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.